Cynthia Myers Haggerty
Cynthia Myers Haggerty
Technical Lab Manager, National Cancer Institute
Verified email at mail.nih.gov
Title
Cited by
Cited by
Year
Alternative splicing of human inducible nitric-oxide synthase mRNA tissue-specific regulation and induction by cytokines
NT Eissa, AJ Strauss, CM Haggerty, EK Choo, SC Chu, J Moss
Journal of biological chemistry 271 (43), 27184-27187, 1996
1361996
Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization
NT Eissa, JW Yuan, CM Haggerty, EK Choo, CD Palmer, J Moss
Proceedings of the National Academy of Sciences 95 (13), 7625-7630, 1998
901998
Transcriptional autoregulation by BRCA1
A De Siervi, P De Luca, JS Byun, LJ Di, T Fufa, CM Haggerty, E Vazquez, ...
Cancer research 70 (2), 532-542, 2010
782010
Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes
JS Byun, MM Wong, W Cui, G Idelman, Q Li, A De Siervi, S Bilke, ...
Proceedings of the National Academy of Sciences 106 (46), 19286-19291, 2009
622009
Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment
JL Smith, WJ Freebern, I Collins, A De Siervi, I Montano, CM Haggerty, ...
Proceedings of the National Academy of Sciences 101 (32), 11554-11559, 2004
572004
Identification of new Rel/NFκB regulatory networks by focused genome location analysis
A De Siervi, P De Luca, C Moiola, G Gueron, R Tongbai, ...
Cell Cycle 8 (13), 2093-2100, 2009
422009
ELL facilitates RNA polymerase II pause site entry and release
JS Byun, TD Fufa, C Wakano, A Fernandez, CM Haggerty, MH Sung, ...
Nature communications 3, 633, 2012
402012
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
Y Ge, I Montano, G Rustici, WJ Freebern, CM Haggerty, W Cui, ...
Blood 108 (13), 4126-4135, 2006
322006
Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells
WG Butscher, CM Haggerty, S Chaudhry, K Gardner
Journal of Biological Chemistry 276 (29), 27647-27656, 2001
302001
Targeting combinatorial transcriptional complex assembly at specific modules within the interleukin-2 promoter by the immunosuppressant SB203580
JL Smith, I Collins, GVR Chandramouli, WG Butscher, E Zaitseva, ...
Journal of Biological Chemistry 278 (42), 41034-41046, 2003
242003
Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations
G Idelman, JG Taylor, R Tongbai, RA Chen, CM Haggerty, S Bilke, ...
Human mutation 28 (8), 824-829, 2007
222007
Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene
S Chaudhry, WJ Freebern, JL Smith, WG Butscher, CM Haggerty, ...
The Journal of Immunology 169 (12), 6767-6778, 2002
222002
Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase
NT Eissa, CM Haggerty, CD Palmer, W Patton, J Moss
American journal of respiratory cell and molecular biology 24 (5), 616-620, 2001
192001
Novel cell-specific and dominant negative anti-apoptotic roles of p73 in transformed leukemia cells
WJ Freebern, JL Smith, SS Chaudhry, CM Haggerty, K Gardner
Journal of Biological Chemistry 278 (4), 2249-2255, 2003
182003
Transcriptional networks inferred from molecular signatures of breast cancer
R Tongbai, G Idelman, SH Nordgard, W Cui, JL Jacobs, CM Haggerty, ...
The American journal of pathology 172 (2), 495-509, 2008
172008
Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2, 4-difluoro-phenyl)-4, 5, 6, 7-tetrafluoro-1H …
Y Ge, JS Byun, P De Luca, G Gueron, IM Yabe, SG Sadiq-Ali, WD Figg, ...
Molecular pharmacology 74 (3), 872-883, 2008
152008
Multimembrane dot-blotting: a cost-effective tool for proteome analysis
MM Galperin, JL Traicoff, A Ramesh, WJ Freebern, CM Haggerty, ...
Biotechniques 36 (6), 1046-1051, 2004
132004
Pharmacologic profiling of transcriptional targets deciphers promoter logic
WJ Freebern, CM Haggerty, I Montano, MC McNutt, I Collins, A Graham, ...
The pharmacogenomics journal 5 (5), 305, 2005
122005
Human promoter genomic composition demonstrates non-random groupings that reflect general cellular function
MC McNutt, R Tongbai, W Cui, I Collins, WJ Freebern, I Montano, ...
BMC bioinformatics 6 (1), 259, 2005
62005
Profiling the expression of mitogen-induced T-cell proteins by using multi-membrane dot-blotting
JL Traicoff, MM Galperin, A Ramesh, WJ Freebern, CM Haggerty, ...
Biochemical and biophysical research communications 323 (1), 355-360, 2004
62004
The system can't perform the operation now. Try again later.
Articles 1–20